Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1985 1
1987 1
1988 2
1990 1
1991 1
1992 2
1994 1
1995 1
1997 2
1998 1
1999 2
2000 10
2001 3
2002 5
2003 14
2004 14
2005 15
2006 26
2007 28
2008 33
2009 46
2010 49
2011 76
2012 77
2013 93
2014 89
2015 111
2016 112
2017 168
2018 166
2019 172
2020 220
2021 291
2022 297
2023 310
2024 416
2025 565
2026 348

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,286 results

Results by year

Filters applied: . Clear all
Page 1
Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis.
Jancev M, Vissers TACM, Visseren FLJ, van Bon AC, Serné EH, DeVries JH, de Valk HW, van Sloten TT. Jancev M, et al. Diabetologia. 2024 May;67(5):798-810. doi: 10.1007/s00125-024-06107-6. Epub 2024 Feb 16. Diabetologia. 2024. PMID: 38363342 Free PMC article.
AIMS/HYPOTHESIS: Continuous glucose monitoring (CGM) is increasingly used in the treatment of type 2 diabetes, but the effects on glycaemic control are unclear. ...We included RCTs investigating real-time CGM (rtCGM) or intermittently sca …
AIMS/HYPOTHESIS: Continuous glucose monitoring (CGM) is increasingly used in the treatment of type 2 d …
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus.
Ajjan RA, Battelino T, Cos X, Del Prato S, Philips JC, Meyer L, Seufert J, Seidu S. Ajjan RA, et al. Nat Rev Endocrinol. 2024 Jul;20(7):426-440. doi: 10.1038/s41574-024-00973-1. Epub 2024 Apr 8. Nat Rev Endocrinol. 2024. PMID: 38589493 Free article. Review.
Although continuous glucose monitoring (CGM) devices are now considered the standard of care for people with type 1 diabetes mellitus, the uptake among people with type 2 diabetes mellitus (T2DM) has been slower and is focused on t …
Although continuous glucose monitoring (CGM) devices are now considered the standard of care for people with type 1 dia …
Efficacy and Safety of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Interventional Evidence.
Seidu S, Kunutsor SK, Ajjan RA, Choudhary P. Seidu S, et al. Diabetes Care. 2024 Jan 1;47(1):169-179. doi: 10.2337/dc23-1520. Diabetes Care. 2024. PMID: 38117991
BACKGROUND: Traditional diabetes self-monitoring of blood glucose (SMBG) involves inconvenient finger pricks. Continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems offer CGM, enhancing type 2 diabete …
BACKGROUND: Traditional diabetes self-monitoring of blood glucose (SMBG) involves inconvenient finger pricks. Continuous …
Continuous Glucose Monitoring Systems in Noninsulin-Treated People with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Ferreira ROM, Trevisan T, Pasqualotto E, Chavez MP, Marques BF, Lamounier RN, van de Sande-Lee S. Ferreira ROM, et al. Diabetes Technol Ther. 2024 Apr;26(4):252-262. doi: 10.1089/dia.2023.0390. Epub 2024 Feb 13. Diabetes Technol Ther. 2024. PMID: 38090767
Introduction: Continuous glucose monitoring (CGM) has shown favorable outcomes in patients with type 2 diabetes (T2D) who are on insulin therapy. However, the efficacy of CGM in managing glucose levels in noninsulin-treated people …
Introduction: Continuous glucose monitoring (CGM) has shown favorable outcomes in patients with type 2 …
Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Uhl S, Choure A, Rouse B, Loblack A, Reaven P. Uhl S, et al. J Clin Endocrinol Metab. 2024 Mar 15;109(4):1119-1131. doi: 10.1210/clinem/dgad652. J Clin Endocrinol Metab. 2024. PMID: 37987208 Free article.
PURPOSE: To provide a systematic review and meta-analysis synthesizing the findings of randomized controlled trials (RCTs) of continuous glucose monitors (CGMs) in the management of adults with type 2 diabetes mellitus (T2DM) on glucos …
PURPOSE: To provide a systematic review and meta-analysis synthesizing the findings of randomized controlled trials (RCTs) of continuous …
Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes.
Davies MJ, Bajaj HS, Broholm C, Eliasen A, Garvey WT, le Roux CW, Lingvay I, Lyndgaard CB, Rosenstock J, Pedersen SD; REDEFINE 2 Study Group. Davies MJ, et al. N Engl J Med. 2025 Aug 14;393(7):648-659. doi: 10.1056/NEJMoa2502082. Epub 2025 Jun 22. N Engl J Med. 2025. PMID: 40544432 Clinical Trial.
Data are needed on the coadministration of cagrilintide and semaglutide (called CagriSema) for weight management in adults with type 2 diabetes, including those in a subgroup who are undergoing continuous glucose monitoring. ...CONCLUSION …
Data are needed on the coadministration of cagrilintide and semaglutide (called CagriSema) for weight management in adults with type …
Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement.
Benhalima K, Durnwald C, Sweeting A, Adams D, Addala A, Battelino T, Bergenstal RM, Carlson A, Donovan LE, Reis Franco D, Heverly J, Isaacs D, Khunti K, Kihara AB, Levitt N, Levy CJ, Lewer M, Mathiesen E, Murphy HR, Nishimura R, Polsky S, Ram U, Simmons D, Yamamoto JM, Tabák ÁG, Feig D, Scott EM. Benhalima K, et al. Lancet Diabetes Endocrinol. 2026 Feb;14(2):157-177. doi: 10.1016/S2213-8587(25)00335-3. Epub 2025 Dec 17. Lancet Diabetes Endocrinol. 2026. PMID: 41421368 Free article. Review.
Insulin resistance increases after the first trimester of pregnancy, leading to glycaemic challenges for women with pregestational type 1 diabetes or type 2 diabetes. Additionally, insulin resistance can promote hyperglycaemia in pregnant women without type 1 …
Insulin resistance increases after the first trimester of pregnancy, leading to glycaemic challenges for women with pregestational type 1 di …
Comparing Continuous Glucose Monitoring and Blood Glucose Monitoring in Adults With Inadequately Controlled, Insulin-Treated Type 2 Diabetes (Steno2tech Study): A 12-Month, Single-Center, Randomized Controlled Trial.
Lind N, Christensen MB, Hansen DL, Nørgaard K. Lind N, et al. Diabetes Care. 2024 May 1;47(5):881-889. doi: 10.2337/dc23-2194. Diabetes Care. 2024. PMID: 38489032 Clinical Trial.
OBJECTIVE: To compare the 12-month effects of continuous glucose monitoring (CGM) versus blood glucose monitoring (BGM) in adults with insulin-treated type 2 diabetes. ...The findings support the use of CGM in the insulin-tr …
OBJECTIVE: To compare the 12-month effects of continuous glucose monitoring (CGM) versus blood glucose monito …
Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes.
Dunn TC, Ajjan RA, Bergenstal RM, Xu Y. Dunn TC, et al. Diabetes Technol Ther. 2024 Mar;26(3):203-210. doi: 10.1089/dia.2023.0565. Diabetes Technol Ther. 2024. PMID: 38444315 Free PMC article. Review.
The growing use of continuous glucose monitoring (CGM) has been supported by expert consensus and clinical guidelines on glycemic management in diabetes with time in range (TIR 70-180 mg/dL) representing a key CGM-derived glucose metric. ...Our real-li …
The growing use of continuous glucose monitoring (CGM) has been supported by expert consensus and clinical guidelines o …
A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.
Kudva YC, Raghinaru D, Lum JW, Graham TE, Liljenquist D, Spanakis EK, Pasquel FJ, Ahmann A, Ahn DT, Aleppo G, Blevins T, Kruger D, Brown SA, Levy CJ, Weinstock RS, Steenkamp DW, Spaic T, Hirsch IB, Broyles F, Rickels MR, Tsoukas MA, Raskin P, Hatipoglu B, Desjardins D, Terry AN, Singh LG, Davis GM, Schmid C, Kravarusic J, Coyne K, Casaubon L, Espinosa V, Jones JK, Estrada K, Afreen S, Levister C, O'Malley G, Liu SL, Marks S, Peleckis AJ, Pasqua MR, Tardio V, Kurek C, Luker RD, Churchill J, Tajrishi FZ, Dean A, Dennis B, Fronczyk E, Perez J, Mukhashen S, Dhillon J, Ipek A, Bzdick S, Atakov Castillo A, Driscoll M, Averkiou X, Dalton-Bakes CV, Moore A, Jordan LF, Lesniak A, Pinsker JE, Sasson-Katchalski R, Campos T, Spanbauer C, Kanapka L, Kollman C, Beck RW; 2IQP Study Group. Kudva YC, et al. N Engl J Med. 2025 May 8;392(18):1801-1812. doi: 10.1056/NEJMoa2415948. Epub 2025 Mar 19. N Engl J Med. 2025. PMID: 40105270 Clinical Trial.
BACKGROUND: Automated insulin delivery (AID) systems have been shown to be beneficial for patients with type 1 diabetes, but data are needed from randomized, controlled trials regarding their role in the management of insulin-treated type 2 diabetes. METHODS: …
BACKGROUND: Automated insulin delivery (AID) systems have been shown to be beneficial for patients with type 1 diabetes, but data are needed …
3,286 results